INVIVOSCRIBE INC.

In News

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial - Business Wire

Business Wire - Jul 08, 2025

CDx FLT3 Mutation Assay in the United Kingdom and Switzerland - Business Wire

Business Wire - Mar 27, 2025

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

PR Newswire - May 09, 2022

Blood Cancer Diagnostics Market Analysis Report 2025-2030, with Quest Diagnostics, Illumina, InVivoScribe, Asuragen, Danaher, Sequenta, SkylineDx, Bio-Rad Laboratories, Alercell & Sophia Genetics - Yahoo Finance

Yahoo Finance - Mar 10, 2025

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay - Via TT

Via TT - Apr 22, 2025

Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China - PR Newswire

PR Newswire - Feb 23, 2023

Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research - Newswire Canada

Newswire Canada - Jun 02, 2023

Blood Cancer Diagnostics Market Size | Industry Report, 2030 - Grand View Research

Grand View Research - Jul 09, 2024

FDA Approves Gilteritinib for FLT3+ Acute Myeloid Leukemia - Medscape

Medscape - Nov 28, 2018

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire

PR Newswire - Aug 16, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment